Yahoo Finance • 4 months ago
In this article, we will take a detailed look at the18 High Growth Low PE Stocks. For a quick overview of such stocks, read our article 5 High Growth Low PE Stocks. When value stocks came back with a vengeance in 2022, value investors che... Full story
Yahoo Finance • 5 months ago
In this article, we will take a look at the 16 most undervalued small-cap stocks to buy according to hedge funds. To see more such companies, go directly to 5 Most Undervalued Small-Cap Stocks To Buy According To Hedge Funds. Despite stro... Full story
Yahoo Finance • 6 months ago
PLYMOUTH MEETING, Pa., Nov. 16, 2023 /PRNewswire/ -- Harmony Biosciences Holdings, Inc. ("Harmony" or the "Company") (Nasdaq: HRMY), a pharmaceutical company dedicated to developing and commercializing innovative therapies for patients wit... Full story
Yahoo Finance • 7 months ago
In this piece, we will take a look at 12 cheap biotechnology stocks that smart investors are piling into. If you want to skip our introduction to the biotechnology industry and how it might be affected by recent economic and stock market t... Full story
Yahoo Finance • a year ago
NEW YORK, June 19, 2023 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Techtronic Industries Company Limited (OTC Pink: TTNDY), Boxed, Inc.... Full story
Yahoo Finance • a year ago
It might be logical to assume that stocks with heavy short interest – i.e., ones that many investors/traders are essentially betting against – are stocks to stay away from, but that is not always the case. Opinions on the stock market can... Full story
Yahoo Finance • a year ago
Dr. Dayno joins Harmony Biosciences Board of Directors PLYMOUTH MEETING, Pa., April 24, 2023 /PRNewswire/ -- Harmony Biosciences Holdings, Inc. ("Harmony" or the "Company") (Nasdaq: HRMY), a pharmaceutical company dedicated to developing... Full story
Yahoo Finance • a year ago
NEW YORK, April 23, 2023 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against LivePerson, Inc. (NASDAQ: LPSN), and Harmony Biosciences Holdings, I... Full story
Yahoo Finance • a year ago
SAN FRANCISCO, April 20, 2023 (GLOBE NEWSWIRE) -- Hagens Berman urges Harmony Biosciences Holdings, Inc. (NASDAQ: HRMY) investors who suffered substantial losses to submit your losses now. Visit:www.hbsslaw.com/investor-fraud/HRMY Cont... Full story
Yahoo Finance • a year ago
NEW YORK, April 02, 2023 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Nutanix, Inc. (NASDAQ: NTNX) and Harmony Biosciences Holdings, Inc.... Full story
Yahoo Finance • a year ago
Investors can contact the law firm at no cost to learn more about recovering their losses LOS ANGELES, March 29, 2023 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises Harmony Biosciences Holdings, Inc. (“Harmony Biosciences” or the “Com... Full story
Yahoo Finance • a year ago
RADNOR, Pa., March 29, 2023 (GLOBE NEWSWIRE) -- The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) is currently investigating potential violations of the federal securities laws on behalf of investors of Harmony Bioscience... Full story
Yahoo Finance • a year ago
SAN DIEGO, March 28, 2023 (GLOBE NEWSWIRE) -- Shareholder rights law firm Johnson Fistel, LLP is investigating whether Harmony Biosciences Holdings, Inc. (NASDAQ: HRMY), any of its executive officers, or others violated securities laws b... Full story
Yahoo Finance • a year ago
ATLANTA, March 28, 2023 (GLOBE NEWSWIRE) -- Holzer & Holzer, LLC is investigating whether Harmony Biosciences Holdings, Inc. (“Harmony Biosciences” or the “Company”) (NASDAQ: HRMY) complied with federal securities laws. On March 28, 2023... Full story
Yahoo Finance • a year ago
In this piece, we will take a look at 13 high growth pharma stocks that are profitable. For more stocks, head on over to 5 High Growth Pharma Stocks that are Profitable. One industry that has rapidly evolved with time and impacted million... Full story
Yahoo Finance • a year ago
At this time, I would like to welcome everyone to Harmony Biosciences' fourth-quarter and full-year 2022 financial results conference call. Good morning, everyone, and thank you for joining us today as we review Harmony Biosciences' fourth... Full story
Yahoo Finance • a year ago
As Novavax Inc. prepares for its next chapter under a new CEO, the Gaithersburg biotech faces a pivotal turning point — still with a chance to change a narrative thus far riddled with just as many setbacks as successes. Industry analysts s... Full story
Yahoo Finance • 2 years ago
WAKIX®(pitolisant) Net Revenue of $117.2 Million for Third Quarter 2022 Increase of ~45% vs. the Same Period in 2021 Average Number of Patients on WAKIX Increased to ~4,600 Prader-Willi Syndrome (PWS) Phase 2 Proof-Of-Concept Study Topli... Full story
Yahoo Finance • 2 years ago
Harmony Biosciences Holdings' (NASDAQ:HRMY) stock up by 8.1% over the past three months. Given its impressive performance, we decided to study the company's key financial indicators as a company's long-term fundamentals usually dictate mar... Full story
Yahoo Finance • 2 years ago
Pharmaceutical companies develop treatments for patients with serious diseases, and when one of these companies has a drug candidate nearing application for review (and, hopefully, approval), the excitement with each piece of news can driv... Full story
Home
Money Search
Trending Sports
Gallery
Shop
Blog
Examples
Data & Glossary
Elements of Bball
Harden Maze
About
